Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies
Keen Eye, a French technology company specialized in image analysis for the life science industry, announced today a strategic partnership agreement with Iris Pharma, a world-wide leading ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services. The partnership aims at providing Iris Pharma artificial intelligence (AI) applications to make assays faster, more reliable and more efficient.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181009005491/en/
For Sylvain Berlemont, Founder & CEO of Keen Eye, “We are very happy to team up and bring our expertise in computer vision to Iris Pharma. Through this partnership, we are expecting to contribute to the most challenging image-based assays to better fight eye diseases”.
For Yann Quentric, President of Iris Pharma, « The advanced AI technology of Keen Eye allows us to optimize the performance of the bioimaging analysis during the preclinical ophthalmic drug development, and in the future for clinical development. Their solution is faster than classical methods, robust and reliable, erasing inter-individual variability, improving Iris Pharma and its customers ability to develop ocular innovative products. »
About Keen Eye
Seeing Beyond Pixels
Founded in 2013, Keen Eye is a technology company based in Paris; aiming
at bringing AI into every laboratory for the benefit of biologists,
pathologists and patients. The company is building decision-support and
GLP-compliant image analysis solutions to accelerate the development of
new therapies with better, faster and accurate analytics.
Keen Eye
develops web-based solutions which help biologists and pathologists that
usually spend thousands of hours on the microscope. Among others, Keen
Eye delivers image quantification applications using its deep learning
technology.
For more information: www.keeneye.tech
About Iris Pharma
A leading CRO dedicated to ophthalmology, Iris Pharma helps clients around the world navigate every stage of the drug and device development process – including in vivo screening, proof of concept, ocular efficacy, GLP preclinical studies, bioanalysis, clinical trials, and marketing surveys. This CRO has expertise in all ophthalmic indications, and supports clients ranging from small start-ups to large pharmaceutical companies in moving forward products that directly or indirectly affect eye health.
For more information: www.iris-pharma.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181009005491/en/
Contact information
Press
Iris Pharma
Yann Quentric
marketing@iris-pharma.com
or
Keen
Eye
Sylvain Berlemont
contact@keeneye.tech
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ProAmpac Releases 2025 Sustainability Impact Report: A Decade of Flexibility. A Future of Possibilities16.7.2025 19:54:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, announces the release of its 2025 Sustainability Impact Report. This year’s theme, A Decade of Flexibility. A Future of Possibilities. celebrates the company’s decade-long journey of sustainable innovation and sets the foundation for its forward-looking climate and packaging goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716418035/en/ ProAmpac's 2025 Sustainability Impact Report “As we celebrate ten years of growth and innovation, we remain focused on what lies ahead: accelerating circular packaging, lowering our carbon footprint, and creating shared value for our employees, customers, communities, and partners. Our journey is far from over, but with every step, our purpose becomes clearer, and our momentum stronger,” said Greg Tucker, founder, vice-chairman, and chief executive officer of ProAmpac. Key highlights from the 2025 Impact Report incl
EBRD Extends Partnership With HTEC Through New Round of Financing16.7.2025 17:25:00 EEST | Press release
The European Bank for Reconstruction and Development (EBRD) is stepping up support for the Serbian technology industry by backing HTEC, a Serbia-founded AI-first engineering services and digital product development company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716157421/en/ EBRD extends partnership with HTEC through new round of financing. The Bank is providing a €60 million loan to support HTEC’s expansion through strategic acquisitions that will further improve the company’s positioning in key markets. The Bank is providing a €60 million loan to support HTEC’s expansion through strategic acquisitions that will further improve the company’s positioning in key markets. HTEC and the EBRD began their partnership in 2020 with a co-financing arrangement alongside the Enterprise Expansion Fund (ENEF), which supported HTEC’s initial acquisition of Execom under its mergers and acquisitions (M&A) strategy. This was foll
OpenX Announces OpenXSelect, an Advanced Supply-Side Targeting and Curation Platform for Brands and Agencies16.7.2025 17:05:00 EEST | Press release
OpenX Technologies, Inc., a leading supply-side platform, today announced the general availability of OpenXSelect™, a next-generation curation and supply-side targeting platform for brands and agencies. Built to bring buyers closer to supply, OpenXSelect enables them to take full control of inventory quality, activate targeting at scale using a wide range of data—including audience, behavioral, attention, and sustainability—and optimize performance through a streamlined, intuitive interface. OpenX has been the leader in supply-side curation since 2018, when it launched OpenAudience™, a first-of-its-kind solution for data partners, powered by the industry’s first supply-side identity graph. OpenAudience set a new standard for activating audiences directly on the supply side and redefined what data-driven curation could look like. OpenXSelect™ builds on that legacy. Developed in close collaboration with leading global brands and agencies, it brings together years of buyer feedback, rigor
Interactive Brokers Unveils Investment Themes Tool to Turn Market Trends into Smarter Trades16.7.2025 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, announced the release of Investment Themes, an intuitive discovery tool powered by Reflexivity that investors can use to move from market trends to actionable trade ideas more quickly and confidently. Available across IBKR’s powerful trading platforms, Investment Themes simplifies the research process by connecting companies, products, competitors, and regions across the entire S&P 1500 universe. The underlying thematic intelligence was developed by Reflexivity, leveraging its proprietary knowledge graph to map the real-world relationships between companies and their business drivers. Investment Themes turns complex market data into clear, interactive insights. Investors can start with a topic like “Generative AI” or “Nuclear Energy” and instantly view the public companies tied to that theme, without needing a ticker symbol or prior research. Investment Themes helps users uncover patterns, explore relationships,
Andersen Consulting Expands Platform with Addition of HTP Group16.7.2025 16:30:00 EEST | Press release
Andersen Consulting continues to expand its consulting capabilities with the addition of collaborating firm Hoffman Talent Partners (HTP Group), an executive search and consulting firm headquartered in Brussels, Belgium. HTP Group helps build impactful leaders for tomorrow’s organizations. HTP provides permanent talent through executive search, interim placements, and as-a-service models, along with leadership and IT consulting services. HTP Group operates through three entities: Hightech Partners, which specializes in executive search and leadership consulting for companies active in the area of digital transformation; Hoffman & Associates, which focuses on executive search and interim management across sectors and functions at board and executive-levels; and Ataya & Partners, which focuses on digital governance and provides cybersecurity and data protection consulting. “Organizations undergoing change require leadership that can keep pace with innovation while maintaining strategic c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom